Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Shares withheld for taxes President and CEO gave up 9,206 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, CMO gave up 4,376 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, CMO gave up 1,310 shares (to pay taxes)
  5. 4 Shares withheld for taxes President and CEO gave up 3,401 shares (to pay taxes)
  6. 4 Open-market sale EVP, CMO sold 5,650 shares at $3.17 ($17,911)
  7. 4 Open-market sale President and CEO sold 18,341 shares at $3.17 ($58,141)
  8. 4/A Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 4,500 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
  18. 4 Open-market sale PAO sold 182 shares at $12.25 ($2,230)
  19. 4 Open-market sale EVP, CMO sold 1,250 shares at $12.25 ($15,313)
  20. 4 Open-market sale President and CEO sold 4,634 shares at $12.25 ($56,767)

Page 14 of 24 · 465 filings